Severe acute pancreatitis
Conditions
Interventions
Control group:Continuous TEA using a drug combination of: nalbuphine 40 mg + ropivacaine 225 mg + lidocaine 0.2 g + 0.9% saline 6 ml in a total volume of 50 ml at an infusion rate of 3-5 ml/h. When th
Experimental group:On the basis of continuous TEA, the pain management nurse led the TEA management strategy based on STM, and when the patients VAS-P exceeded a score of 3 or pain was intolerable, an
Sponsors
Affiliated Hospital of Zunyi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patient age>=18 years. 2. Patients with a clear diagnosis of SAP. 3. Pain score greater than 3 points. 4. Need for effective epidural analgesic pain management. 5. The patient or his/her legal representative signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to epidural analgesia, such as coagulation dysfunction, local infection, allergy to lidocaine, etc. Combined with severe heart, lung, liver, renal failure, severe infection, malignant diseases and autoimmune diseases. 2. Patients with pancreatic pseudocyst and infection. 3. Patients who voluntarily sign off and are discharged during the ICU hospitalization or throughout the hospitalization. 4. Patients with incomplete medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Assessment Scale-Pain (VAS-P); | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra-abdominal pressure (IAP);Dosage of combined drugs(DCD;Number of additional interventions(NAI);Number of days of epidural placement(NDEP); | — |
Countries
China
Contacts
Public ContactYou Yuan
Affiliated Hospital of Zunyi Medical University
Outcome results
None listed